Evidence map›Paper›PMID 42198979›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2026

[Hierarchical attention-driven multiple instance learning for clear cell renal cell carcinoma grading and staging in digital pathology].

Jianing Xu, Yixiao Mao, Yu Zhang

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jianing XuSchool of Biomedical Engineering//Guangdong Provincial Key Laboratory of Medical Image Processing, Southern Medical University, Guangzhou 510515, China.
Yixiao MaoSchool of Biomedical Engineering//Guangdong Provincial Key Laboratory of Medical Image Processing, Southern Medical University, Guangzhou 510515, China.
Yu ZhangSchool of Biomedical Engineering//Guangdong Provincial Key Laboratory of Medical Image Processing, Southern Medical University, Guangzhou 510515, China.

Funding

National Natural Science Foundation of China 82472056
6 · The paper itself

Abstract

objectivesTo develop a hierarchical attention-driven multiple instance learning (HA-MIL) framework for precise grading and staging of clear cell renal cell carcinoma (ccRCC).

methodsWhole-slide images (WSIs) and the corresponding clinicopathological labels were obtained from 504 patients from the TCGA-KIRC database. The proposed HA-MIL framework processes WSIs by segmenting them into patches, leverages a hierarchical attention mechanism to discern the significance of instances across different levels and incorporates a dynamic gated fusion module to refine feature aggregation. This approach mitigates the dependency on subjective evaluations by pathologists.

resultsExperimental results showed that HA-MIL achieved an accuracy of (87.35±0.72)%, an AUC of 0.95, and an F1-score of (86.41±0.63)% in the staging task. For the grading task, the model attained an accuracy of (85.82±0.60)%, an AUC of 0.93, and an F1-score of (86.00±0.65)%. HA-MIL demonstrated significantly higher accuracy and robustness compared to the baseline methods including SVM, DSMIL, and ABMIL. Ablation studies confirmed the contribution of the hierarchical attention mechanism, which improved the accuracy and F1-score by 3.2% and 2.2%, respectively, outperforming the conventional attention mechanisms.

conclusionsThe HA-MIL framework exhibits superior performance for grading and staging of ccRCC, thus offering a novel, intelligent method for pathological image analysis of ccRCC in the clinical setting.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsHumansMultiple-Instance Learning AlgorithmsNeoplasm GradingNeoplasm Stagingattention mechanismclear cell renal cell carcinomadeep learninggrading and stagingmultiple instance learning

Identifiers

PMID42198979
PMCPMC13213364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.